YME1L-mediated metabolic reprogramming of mitochondria supports the growth of pancreatic ductal adenocarcinoma cells and may be relevant to the pathophysiology of these tumours18. The gene discussed is YME1L1; the disease is pancreatic ductal adenocarcinoma.